See also: Generic Ambien CR
Ambien is a brand name of zolpidem, approved by the FDA in the following formulation(s):
AMBIEN (zolpidem tartrate - tablet; oral)
Manufacturer: SANOFI AVENTIS US
Approval date: December 16, 1992
Strength(s): 10MG [RLD][AB], 5MG [AB]
Has a generic version of Ambien been approved?
A generic version of Ambien has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Ambien and have been approved by the FDA:
zolpidem tartrate tablet; oral
Manufacturer: APOTEX INC
Approval date: April 23, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: AUROBINDO PHARMA
Approval date: May 4, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: CARACO
Approval date: April 23, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: CARLSBAD
Approval date: April 23, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: DR REDDYS LABS LTD
Approval date: April 23, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: HIKMA
Approval date: April 30, 2008
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: INVAGEN PHARMS
Approval date: September 7, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: LEK PHARMS DD
Approval date: April 23, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: MYLAN
Approval date: April 23, 2007
Strength(s): 10MG [AB], 10MG [AB], 5MG [AB], 5MG [AB]
Manufacturer: RANBAXY
Approval date: April 23, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: ROXANE
Approval date: April 23, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: TEVA
Approval date: April 23, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: TORRENT PHARMS
Approval date: August 17, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: VINTAGE
Approval date: November 21, 2008
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: WATSON LABS
Approval date: April 23, 2007
Strength(s): 10MG [AB], 5MG [AB]
Manufacturer: WOCKHARDT
Approval date: May 15, 2007
Strength(s): 10MG [AB], 5MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ambien. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Ambien.
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- September 29, 2010 - PEDIATRIC EXCLUSIVITY
See also...
- Ambien Consumer Information (Drugs.com)
- Ambien Consumer Information (Wolters Kluwer)
- Ambien Consumer Information (Cerner Multum)
- Ambien Advanced Consumer Information (Micromedex)
- Ambien AHFS DI Monographs (ASHP)
- Zolpidem Consumer Information (Drugs.com)
- Zolpidem Consumer Information (Wolters Kluwer)
- Zolpidem Extended-Release Tablets Consumer Information (Wolters Kluwer)
- Zolpidem Oral Spray Consumer Information (Wolters Kluwer)
- Zolpidem Consumer Information (Cerner Multum)
- Zolpidem Oral, Oromucosal Advanced Consumer Information (Micromedex)
- Zolpidem Tartrate AHFS DI Monographs (ASHP)
No comments:
Post a Comment